Singapore Institute of Advanced Medicine Holdings Ltd. (SIAMH): Detailed AGM Report and Investor Insights

Key Highlights from the Annual General Meeting (AGM) Held on 28 October 2025

Singapore Institute of Advanced Medicine Holdings Ltd. (“SIAMH” or the “Company”) conducted its Annual General Meeting on 28 October 2025 at 1 Biopolis Drive, Singapore. The meeting covered crucial resolutions that set the tone for the Company’s governance, strategic direction, and remuneration in the coming year. Below is a comprehensive breakdown and analysis of the AGM proceedings, with particular emphasis on matters that may impact shareholder value and the Company’s outlook.

1. Board Composition and Attendance

• Mr Khoo Tiam Hock Vernon chaired the meeting. He is also an Independent Director.
• Directors present included:
  • Dr Djeng Shih Kien – Executive Director & CEO
  • Mr Yeo Seng Lye Paul – Executive Director & COO
  • Ms Vivienne Cheng Chi Fan – Non-Executive, Non-Independent Director
  • Mr Gurdip Singh S/O Boor Singh – Independent Director
  • Ms Sumei Shum – Independent Director
• Dato’ Lee Kok Chuan, a Non-Executive and Non-Independent Director, was absent with apologies.

2. Adoption of Audited Financial Statements

• The audited financial statements for the financial year ended 30 June 2025, along with the Directors’ Statement and Independent Auditor’s Report, were unanimously adopted. This indicates solid financial reporting and transparency for the Group.

3. Directors’ Fees

• Shareholders approved the payment of S\$200,000 in Directors’ fees for the financial year ending 30 June 2026, to be paid half-yearly in arrears. This is a clear indication of the Board’s remuneration structure and its alignment with market practices.
• The Chairman, Mr Vernon Khoo, recused himself from this agenda item to avoid conflict of interest, underscoring good governance practices.

4. Re-Election of Directors

• The following Directors were re-elected, each having retired by rotation pursuant to the Company’s Constitution and having indicated their willingness to continue:
  • Dr Djeng Shih Kien
  • Mr Khoo Tiam Hock Vernon (Chairman)
  • Ms Sumei Shum
• This continuity in the Board provides stability and ongoing strategic direction for the Company.

5. Re-Appointment of Auditors

• Messrs Foo Kon Tan LLP were re-appointed as the Company’s auditors, with authority given to the Directors to fix their remuneration. The re-appointment points to satisfaction with the auditors’ independence and performance.

6. Authority to Issue Shares and Convertible Securities

• Shareholders granted the Board authority to:
  • Allot and issue new shares and convertible securities up to 100% of the issued share capital, with up to 50% allowed on a non-pro-rata basis.
  • This authority is subject to SGX Catalist Rules and the Companies Act, and remains valid until the next AGM or as required by law.
• Potential Price-Sensitivity: This resolution enables SIAMH to rapidly raise capital for expansion, acquisitions, or other corporate actions without convening an EGM every time, potentially accelerating growth or strategic initiatives. Such flexibility can be viewed positively by investors looking for agility and capital market responsiveness.

7. Performance Share Plan (PSP): Authority to Grant Awards and Issue Shares

• Shareholders approved the authority for Directors to grant awards and issue shares under the SIAMH Performance Share Plan, capped at 15% of the issued shares at any point.
• Potential Price-Sensitivity: The PSP aligns management and employee incentives with shareholder interests, potentially driving superior performance. However, it also introduces possible dilution if significant awards are made, which investors should monitor closely.

8. Poll Results

• All resolutions were passed with near-unanimous or unanimous support, with the only dissent being a negligible 20,000 shares (out of 789,449,280) voting against the Directors’ fees resolution.
• This overwhelming approval signals strong shareholder confidence in the Board and management.

9. Other Noteworthy Points

• No questions were raised by shareholders prior to or during the meeting, suggesting either satisfaction with disclosures or a lack of contentious issues.
• The Company’s listing date was 16 February 2024, making this its first or one of its early AGMs as a listed entity. Early-stage listed companies often see significant strategic developments as they establish public market credibility.

Potentially Price-Sensitive or Shareholder-Impacting Developments

• Capital Raising Flexibility: The broad authority to issue up to 100% of capital (with 50% non-pro-rata) positions SIAMH for potential fundraising, strategic investments, or acquisitions, which could materially impact share value depending on execution and market conditions.
• Performance Share Plan Implementation: The Board now has the power to incentivize management through share-based rewards, promoting alignment with shareholders but also introducing dilution risk if not carefully managed.
• Board Continuity and Governance: Stability in Board composition and strong approval of resolutions reflect well on corporate governance, which can be positively viewed by institutional investors.

Conclusion

The 2025 AGM of SIAMH was significant in affirming the Board’s mandate, approving flexible capital-raising mechanisms, and implementing incentive plans that could drive long-term performance. Investors should monitor for future share issuances or grants under the PSP, as these could affect both dilution and growth prospects. With all resolutions strongly supported, SIAMH appears well-positioned to pursue its strategic objectives in the coming year.

Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with professional advisors before making investment decisions. The information is based on official AGM minutes and public disclosures as of the date of reporting and may be subject to change.

View SAM Holdings Historical chart here